US2020146660A1PendingUtilityA1

Sinus venosus atrial septal defect treatment device

Assignee: ALANBAEI MUATHPriority: Feb 13, 2017Filed: Jan 10, 2020Published: May 14, 2020
Est. expiryFeb 13, 2037(~10.5 yrs left)· nominal 20-yr term from priority
Inventors:Muath Alanbaei
A61F 2250/0039A61B 2090/3966A61B 2017/00243A61B 2017/00606A61B 2017/00575A61B 2017/1107A61B 2017/00597A61B 2017/00853A61B 2017/00557A61B 2017/00623A61B 17/0057A61F 2/82A61F 2002/9583A61F 2002/825A61B 2017/00592A61F 2/958A61F 2/06
42
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The sinus venosus atrial septal defect (“ASD”) treatment device includes has a generally tubular or funnel shaped configuration. A first end of the device can have a diameter that is less than a diameter of a second end of the device. The device can be inserted in the right upper right pulmonary vein PV. The second end of the device is configured to expand in a skirt-like configuration once the device is positioned in the right upper right pulmonary vein PV. In this manner, the device closes the upper sinus venosus hole and diverts anomalous pulmonary venous drainage into the left atrium.

Claims

exact text as granted — not AI-modified
1 . A sinus venosus atrial septal defect treatment device, comprising:
 a tubular body having opposed first and second open ends, the body being defined by:
 a proximal portion having an expandable peripheral wall, the expandable peripheral wall of the proximal portion including a balloon catheter locking system on an exterior surface thereof; 
 a distal portion having an expandable peripheral wall, the expandable peripheral wall of the distal portion including an expandable septal augmenter rim at an edge portion thereof; and 
 a central portion between the proximal portion and the distal portion, the central portion including an expandable peripheral wall.

Join the waitlist — get patent alerts

Track US2020146660A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.